These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 17760404)
41. Pathogenesis and management of the hepatorenal syndrome. Laffi G; La Villa G; Gentilini P Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664 [No Abstract] [Full Text] [Related]
42. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy. Arroyo V Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402 [TBL] [Abstract][Full Text] [Related]
43. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. Arroyo V; Terra C; Ginès P J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801 [No Abstract] [Full Text] [Related]
45. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P; Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512 [TBL] [Abstract][Full Text] [Related]
50. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Moreau R; Lebrec D Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352 [TBL] [Abstract][Full Text] [Related]
55. [Diagnostics and therapy of hepatorenal syndrome. Recommendations of of the working group on portal hypertension of the Czech Hepatology Society and the J. E. Purkinje Czech Medical Society]. Brůha R; Skupiny C; Balihar K; Drastich P; Hůlek P; Lata J; Petrtýl J; Procházka V; Spicák J; Vanásek T; Volfová M; Zdenek P; ; Vnitr Lek; 2006 Jun; 52(6):649-50. PubMed ID: 16871772 [TBL] [Abstract][Full Text] [Related]
56. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036 [No Abstract] [Full Text] [Related]
57. Pathogenesis of ascites in cirrhosis and portal hypertension. Heneghan MA; Harrison PM Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415 [TBL] [Abstract][Full Text] [Related]
58. Hepatorenal syndrome: a comprehensive overview for the critical care nurse. Fleming JN; Abou Abbass A Crit Care Nurs Clin North Am; 2010 Sep; 22(3):351-68. PubMed ID: 20691386 [TBL] [Abstract][Full Text] [Related]
59. Review article: Management of ascites and associated complications in patients with cirrhosis. Kuiper JJ; de Man RA; van Buuren HR Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661 [TBL] [Abstract][Full Text] [Related]